$CRMZ
CREDITRISKMONITOR COM INC

2023 Q2 Form 10-Q Financial Statement

#000114036123024303 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $4.682M $4.591M $4.643M
YoY Change 5.22% 5.82% 6.49%
Cost Of Revenue $1.934M $1.920M $1.867M
YoY Change 12.76% 9.85% 15.89%
Gross Profit $2.748M $2.670M $2.777M
YoY Change 0.5% 3.1% 0.98%
Gross Profit Margin 58.69% 58.17% 59.8%
Selling, General & Admin $2.253M $2.359M $2.176M
YoY Change -3.85% 2.53% 26.61%
% of Gross Profit 81.97% 88.34% 78.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $94.57K $97.52K $80.68K
YoY Change -11.62% 3.51% -10.57%
% of Gross Profit 3.44% 3.65% 2.91%
Operating Expenses $4.282M $4.377M $2.257M
YoY Change 2.79% 5.64% 24.76%
Operating Profit $401.0K $213.8K $519.5K
YoY Change 40.83% 9.66% -44.76%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $192.6K $141.0K $114.4K
YoY Change 1636.42% 20126.4% 1742.03%
Pretax Income $593.6K $354.8K $633.9K
YoY Change 100.64% 81.31% -74.73%
Income Tax $142.2K $79.51K $123.5K
% Of Pretax Income 23.96% 22.41% 19.48%
Net Earnings $451.4K $275.3K $510.5K
YoY Change 112.23% 82.16% -78.35%
Net Earnings / Revenue 9.64% 6.0% 10.99%
Basic Earnings Per Share $0.04 $0.03
Diluted Earnings Per Share $0.04 $0.03 $0.05
COMMON SHARES
Basic Shares Outstanding 10.72M 10.72M 10.72M
Diluted Shares Outstanding 10.81M 10.80M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.51M $13.70M $13.90M
YoY Change 14.93% 12.32% 12.23%
Cash & Equivalents $10.45M $9.644M $9.867M
Short-Term Investments $4.063M $4.054M $4.029M
Other Short-Term Assets $951.0K $656.5K $656.4K
YoY Change 17.36% 25.72% 12.95%
Inventory
Prepaid Expenses
Receivables $2.921M $3.412M $3.500M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.38M $17.77M $18.05M
YoY Change 8.88% 12.19% 14.5%
LONG-TERM ASSETS
Property, Plant & Equipment $561.2K $593.6K $2.298M
YoY Change -1.99% -76.69% 279.14%
Goodwill $1.954M $1.954M $1.954M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.11K $18.11K $163.5K
YoY Change -63.14% -76.6% 88.52%
Total Long-Term Assets $4.249M $4.333M $4.416M
YoY Change -5.39% -5.37% -5.22%
TOTAL ASSETS
Total Short-Term Assets $18.38M $17.77M $18.05M
Total Long-Term Assets $4.249M $4.333M $4.416M
Total Assets $22.63M $22.10M $22.47M
YoY Change 5.88% 8.26% 10.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $91.64K $122.1K $245.9K
YoY Change -59.35% -28.49% -31.39%
Accrued Expenses $1.721M $1.194M $2.410M
YoY Change 17.76% -13.7% 38.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.18M $12.01M $12.64M
YoY Change -0.77% 3.47% 7.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.775M $1.884M $1.929M
YoY Change -15.21% -10.54% -7.56%
Total Long-Term Liabilities $1.775M $1.884M $1.929M
YoY Change -15.21% -10.54% -7.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.18M $12.01M $12.64M
Total Long-Term Liabilities $1.775M $1.884M $1.929M
Total Liabilities $14.28M $14.23M $14.90M
YoY Change -3.8% 0.79% 4.21%
SHAREHOLDERS EQUITY
Retained Earnings -$21.72M -$22.17M -$22.44M
YoY Change -7.35% -5.71%
Common Stock $107.2K $107.2K $107.2K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.350M $7.873M $7.570M
YoY Change
Total Liabilities & Shareholders Equity $22.63M $22.10M $22.47M
YoY Change 5.88% 8.26% 10.0%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $451.4K $275.3K $510.5K
YoY Change 112.23% 82.16% -78.35%
Depreciation, Depletion And Amortization $94.57K $97.52K $80.68K
YoY Change -11.62% 3.51% -10.57%
Cash From Operating Activities $836.5K -$175.1K $323.1K
YoY Change 57.94% 51.23% -58.17%
INVESTING ACTIVITIES
Capital Expenditures $62.16K $53.66K $61.04K
YoY Change -163.9% -176.27% -171.72%
Acquisitions
YoY Change
Other Investing Activities $31.72K $6.010K -$4.001M
YoY Change
Cash From Investing Activities -$30.43K -$47.66K -$4.062M
YoY Change -68.72% -32.27% 4673.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 836.5K -175.1K 323.1K
Cash From Investing Activities -30.43K -47.66K -4.062M
Cash From Financing Activities
Net Change In Cash 806.1K -222.7K -3.739M
YoY Change 86.43% 19.66% -643.93%
FREE CASH FLOW
Cash From Operating Activities $836.5K -$175.1K $323.1K
Capital Expenditures $62.16K $53.66K $61.04K
Free Cash Flow $774.3K -$228.7K $262.1K
YoY Change 23.52% 403.71% -69.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19332
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
306650
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
239100
CY2023Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
231950
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10797101
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10748568
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000315958
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27901
CY2023Q1 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
8964
CY2022Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
4054252
CY2023Q1 us-gaap Other Than Temporary Impairment Losses Investments Heldtomaturity Securities
OtherThanTemporaryImpairmentLossesInvestmentsHeldtomaturitySecurities
0
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10722401
CY2022Q1 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
212933
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
155700

Files In Submission

Name View Source Status
0001140361-23-024303-index-headers.html Edgar Link pending
0001140361-23-024303-index.html Edgar Link pending
0001140361-23-024303.txt Edgar Link pending
0001140361-23-024303-xbrl.zip Edgar Link pending
brhc20052520_10q.htm Edgar Link pending
brhc20052520_ex31-1.htm Edgar Link pending
brhc20052520_ex31-2.htm Edgar Link pending
brhc20052520_ex32-1.htm Edgar Link pending
brhc20052520_ex32-2.htm Edgar Link pending
crmz-20230331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
crmz-20230331_def.xml Edgar Link unprocessable
crmz-20230331_cal.xml Edgar Link unprocessable
crmz-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
crmz-20230331_pre.xml Edgar Link unprocessable
brhc20052520_10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending